187 related articles for article (PubMed ID: 27030700)
1. Arrhythmogenicity of Anti-Ro/SSA Antibodies in Patients With Torsades de Pointes.
Lazzerini PE; Yue Y; Srivastava U; Fabris F; Capecchi PL; Bertolozzi I; Bacarelli MR; Morozzi G; Acampa M; Natale M; El-Sherif N; Galeazzi M; Laghi-Pasini F; Boutjdir M
Circ Arrhythm Electrophysiol; 2016 Apr; 9(4):e003419. PubMed ID: 27030700
[TBL] [Abstract][Full Text] [Related]
2. Induction of autoimmune response to the extracellular loop of the HERG channel pore induces QTc prolongation in guinea-pigs.
Fabris F; Yue Y; Qu Y; Chahine M; Sobie E; Lee P; Wieczorek R; Jiang XC; Capecchi PL; Laghi-Pasini F; Lazzerini PE; Boutjdir M
J Physiol; 2016 Nov; 594(21):6175-6187. PubMed ID: 27296897
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of the Novel Autoimmune-Associated Long-QT Syndrome.
Yue Y; Castrichini M; Srivastava U; Fabris F; Shah K; Li Z; Qu Y; El-Sherif N; Zhou Z; January C; Hussain MM; Jiang XC; Sobie EA; Wahren-Herlenius M; Chahine M; Capecchi PL; Laghi-Pasini F; Lazzerini PE; Boutjdir M
Circulation; 2015 Jul; 132(4):230-40. PubMed ID: 25995318
[TBL] [Abstract][Full Text] [Related]
4. Anti-Ro/SSA Antibodies and the Autoimmune Long-QT Syndrome.
Lazzerini PE; Laghi-Pasini F; Boutjdir M; Capecchi PL
Front Med (Lausanne); 2021; 8():730161. PubMed ID: 34552948
[TBL] [Abstract][Full Text] [Related]
5. Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity.
Lazzerini PE; Capecchi PL; Acampa M; Morozzi G; Bellisai F; Bacarelli MR; Dragoni S; Fineschi I; Simpatico A; Galeazzi M; Laghi-Pasini F
Arthritis Care Res (Hoboken); 2011 Oct; 63(10):1463-70. PubMed ID: 21739618
[TBL] [Abstract][Full Text] [Related]
6. Development of models for predicting Torsade de Pointes cardiac arrhythmias using perceptron neural networks.
Sharifi M; Buzatu D; Harris S; Wilkes J
BMC Bioinformatics; 2017 Dec; 18(Suppl 14):497. PubMed ID: 29297274
[TBL] [Abstract][Full Text] [Related]
7. Human ether-a-go-go-related (HERG) gene and ATP-sensitive potassium channels as targets for adverse drug effects.
Zünkler BJ
Pharmacol Ther; 2006 Oct; 112(1):12-37. PubMed ID: 16647758
[TBL] [Abstract][Full Text] [Related]
8. Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes.
Lazzerini PE; Laghi-Pasini F; Bertolozzi I; Morozzi G; Lorenzini S; Simpatico A; Selvi E; Bacarelli MR; Finizola F; Vanni F; Lazaro D; Aromolaran A; El Sherif N; Boutjdir M; Capecchi PL
Heart; 2017 Nov; 103(22):1821-1829. PubMed ID: 28490617
[TBL] [Abstract][Full Text] [Related]
9. Oxycodone is associated with dose-dependent QTc prolongation in patients and low-affinity inhibiting of hERG activity in vitro.
Fanoe S; Jensen GB; Sjøgren P; Korsgaard MP; Grunnet M
Br J Clin Pharmacol; 2009 Feb; 67(2):172-9. PubMed ID: 19159406
[TBL] [Abstract][Full Text] [Related]
10. Probucol aggravates long QT syndrome associated with a novel missense mutation M124T in the N-terminus of HERG.
Hayashi K; Shimizu M; Ino H; Yamaguchi M; Terai H; Hoshi N; Higashida H; Terashima N; Uno Y; Kanaya H; Mabuchi H
Clin Sci (Lond); 2004 Aug; 107(2):175-82. PubMed ID: 15043509
[TBL] [Abstract][Full Text] [Related]
11. Risk of QTc Interval Prolongation Associated With Circulating Anti-Ro/SSA Antibodies Among US Veterans: An Observational Cohort Study.
Lazzerini PE; Cevenini G; Qu YS; Fabris F; El-Sherif N; Acampa M; Cartocci A; Laghi-Pasini F; Capecchi PL; Boutjdir M; Lazaro D
J Am Heart Assoc; 2021 Feb; 10(4):e018735. PubMed ID: 33533258
[TBL] [Abstract][Full Text] [Related]
12. Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug-associated torsades de pointes.
Lehtonen A; Fodstad H; Laitinen-Forsblom P; Toivonen L; Kontula K; Swan H
Heart Rhythm; 2007 May; 4(5):603-7. PubMed ID: 17467628
[TBL] [Abstract][Full Text] [Related]
13. Beat-by-beat QT interval variability, but not QT prolongation per se, predicts drug-induced torsades de pointes in the anaesthetised methoxamine-sensitized rabbit.
Jacobson I; Carlsson L; Duker G
J Pharmacol Toxicol Methods; 2011; 63(1):40-6. PubMed ID: 20451633
[TBL] [Abstract][Full Text] [Related]
14. Role of a KCNH2 polymorphism (R1047 L) in dofetilide-induced Torsades de Pointes.
Sun Z; Milos PM; Thompson JF; Lloyd DB; Mank-Seymour A; Richmond J; Cordes JS; Zhou J
J Mol Cell Cardiol; 2004 Nov; 37(5):1031-9. PubMed ID: 15522280
[TBL] [Abstract][Full Text] [Related]
15. Anti-Ro/SSA Antibodies Blocking Calcium Channels as a Potentially Reversible Cause of Atrioventricular Block in Adults.
Lazzerini PE; Murthy Ginjupalli VK; Srivastava U; Bertolozzi I; Bacarelli MR; Verrengia D; Salvini V; Accioli R; Carbone SF; Santoro A; Cartocci A; Cevenini G; Cantara S; Cantore A; Bisogno S; Brucato A; Laghi-Pasini F; Acampa M; Capecchi PL; Boutjdir M
JACC Clin Electrophysiol; 2023 Aug; 9(8 Pt 3):1631-1648. PubMed ID: 37227349
[TBL] [Abstract][Full Text] [Related]
16. Torsades de pointes during complete atrioventricular block: Genetic factors and electrocardiogram correlates.
Subbiah RN; Gollob MH; Gula LJ; Davies RW; Leong-Sit P; Skanes AC; Yee R; Klein GJ; Krahn AD
Can J Cardiol; 2010 Apr; 26(4):208-12. PubMed ID: 20386770
[TBL] [Abstract][Full Text] [Related]
17. Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA-positive connective tissue diseases.
Lazzerini PE; Acampa M; Guideri F; Capecchi PL; Campanella V; Morozzi G; Galeazzi M; Marcolongo R; Laghi-Pasini F
Arthritis Rheum; 2004 Apr; 50(4):1248-52. PubMed ID: 15077308
[TBL] [Abstract][Full Text] [Related]
18. A history of the role of the hERG channel in cardiac risk assessment.
Rampe D; Brown AM
J Pharmacol Toxicol Methods; 2013; 68(1):13-22. PubMed ID: 23538024
[TBL] [Abstract][Full Text] [Related]
19. Comparative pharmacology of guinea pig cardiac myocyte and cloned hERG (I(Kr)) channel.
Davie C; Pierre-Valentin J; Pollard C; Standen N; Mitcheson J; Alexander P; Thong B
J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1302-9. PubMed ID: 15574182
[TBL] [Abstract][Full Text] [Related]
20. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
